Christian Heidbreder
Chief Tech/Sci/R&D Officer chez INDIVIOR PLC
Fortune : 2 M $ au 31/03/2024
Profil
Christian Heidbreder is currently the Chief Scientific Officer at Indivior PLC since 2014.
He is also a Professor at the Medical College of Virginia.
Previously, he worked as the Global Director-Research & Development at Reckitt Benckiser Pharmaceuticals, Inc. He completed his undergraduate, graduate, and doctorate degrees from the Université Catholique de Louvain.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INDIVIOR PLC
0,07% | 06/03/2024 | 92 922 ( 0,07% ) | 2 M $ | 31/03/2024 |
Postes actifs de Christian Heidbreder
| Sociétés | Poste | Début |
|---|---|---|
| INDIVIOR PLC | Chief Tech/Sci/R&D Officer | 01/12/2014 |
| Medical College of Virginia | Corporate Officer/Principal | - |
Anciens postes connus de Christian Heidbreder
| Sociétés | Poste | Fin |
|---|---|---|
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Corporate Officer/Principal | - |
Formation de Christian Heidbreder
| Université Catholique de Louvain | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Reckitt Benckiser Pharmaceuticals, Inc.
Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Health Technology |
